Axiom Investors’s Teladoc Health TDOC Stock Holding History

Axiom Investors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,410	Closed	-$1.22M	–	121
2020 Q2	$1.22M	Sell	6,410 -27,994	-81%	-$4.91M	0.02%	106
2020 Q1	$5.33M	Sell	34,404 -25,314	-42%	-$2.95M	0.14%	63
2019 Q4	$5M	Buy	59,718 +29,068	+95%	+$2.21M	0.12%	75
2019 Q3	$2.08M	Sell	30,650 -9,350	-23%	-$615K	0.06%	96
2019 Q2	$2.66M	Buy	40,000 +6,615	+20%	+$386K	0.07%	89
2019 Q1	$1.86M	Sell	33,385 -10,000	-23%	-$611K	0.06%	102
2018 Q4	$2.15M	Sell	43,385 -46,695	-52%	-$2.86M	0.08%	106
2018 Q3	$7.78M	Buy	90,080 +5,890	+7%	+$420K	0.22%	63
2018 Q2	$4.89M	Sell	84,190 -8,220	-9%	-$401K	0.15%	88
2018 Q1	$3.72M	Buy	+92,410	New	+$3.49M	0.09%	102

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DVF

Discovery Value Fund Singapore $39.8M AUM 27.89% 1-Year Est. Return

Axiom Investors's TDOC Position: Q3 2020 in Review

Axiom Investors sold out of Teladoc Health (TDOC) in Q3 2020, closing a stake of 6,410 shares — an estimated $1.22M sold.

Axiom Investors first reported a position in TDOC in Q1 2018 and held it in 10 quarters. The position peaked at $7.78M in Q3 2018. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

Axiom Investors reported no remaining Teladoc Health position as of Q3 2020 after selling out during the quarter.
Axiom Investors sold 6,410 Teladoc Health shares in Q3 2020, an estimated $1.22M.
Axiom Investors first reported a position in Teladoc Health in Q1 2018 and held it in 10 quarters.
Axiom Investors's Teladoc Health position peaked at $7.78M in Q3 2018.
743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on Axiom Investors's 13F filing for Q3 2020, filed 12 Nov 2020.